Translational control in cancer

Nat Rev Cancer. 2010 Apr;10(4):254-66. doi: 10.1038/nrc2824.


Remarkable progress has been made in defining a new understanding of the role of mRNA translation and protein synthesis in human cancer. Translational control is a crucial component of cancer development and progression, directing both global control of protein synthesis and selective translation of specific mRNAs that promote tumour cell survival, angiogenesis, transformation, invasion and metastasis. Translational control of cancer is multifaceted, involving alterations in translation factor levels and activities unique to different types of cancers, disease stages and the tumour microenvironment. Several clinical efforts are underway to target specific components of the translation apparatus or unique mRNA translation elements for cancer therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Cell Transformation, Neoplastic / genetics
  • Eukaryotic Initiation Factor-3 / genetics
  • Homeostasis / genetics
  • Humans
  • Models, Genetic
  • Neoplasm Staging
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Prokaryotic Initiation Factors / genetics
  • Protein Biosynthesis*
  • RNA, Messenger / genetics
  • Ribosomes / genetics


  • Eukaryotic Initiation Factor-3
  • Prokaryotic Initiation Factors
  • RNA, Messenger